Back to Agenda
Juvenile Animal Studies and Pediatric Nonclinical Development
Session Chair(s)
Dinah Duarte, MSC
Signal Management Lead, European Medicines Agency, Netherlands
Juvenile Animal Studies and Pediatric Nonclinical Development: EU Perspective
Learning Objective : Discuss the importance of nonclinical juvenile animal guidance in pediatric drug development; Share real world experience from available historical data on juvenile animal studies; Examine if juvenile animal studies in nonclinical support for pediatric drug development has significantly changed.
Speaker(s)
Dinah Duarte, MSC
Signal Management Lead, European Medicines Agency, Netherlands
Juvenile Animal Studies and Pediatric Nonclinical Development: EU Perspective
Mark E Hurtt, PHD
Executive Director and Global Head, DSRD Centers of Emphasis, Pfizer Inc, United States
Juvenile Animal Studies and Pediatric Nonclinical Development: Industry Perspective
Have an account?